Dermatology Conference Highlights 2024: Atopic Dermatitis

Share:

Recent Articles:

Seemal Desai, MD, FAAD: Assessing Efficacy of Ruxolitinib in Characteristic Subgroups for Patients with Vitiligo
Julie Harper, MD: What's New in Rosacea
Clive Maopang Liu, MD: Update on Topical Therapy for Psoriasis
Steven Daniel Daveluy, MD, FAAD: AI Phenotyping of Hidradenitis Suppurativa
Nada Elbuluk, MD: Skin of Color Primer—Inflammatory Diseases
Saakshi Khattri, MD: Psoriatic Arthritis Update
Jeffrey Cohen, MD, MPH: Treatment of Psoriasis in High-impact Sites
Ashish Bhatia, MD: New Technologies in Dermatology
Experiences of Social Media Users with Over the Counter Red Light Therapy Devices
Improving Molluscum Treatment Options: Overcoming the Challenge of Poor Adherence
1 2 3 166

Categories:

Recent Articles:

Seemal Desai, MD, FAAD: Assessing Efficacy of Ruxolitinib in Characteristic Subgroups for Patients with Vitiligo
Raj Chovatiya, MD, PhD: Maintaining Optimal Treatment Targets with Upadacitinib for Patients with Atopic Dermatitis
Jennifer Hsiao, MD: Dual Biologic Management in Hidradenitis Suppurativa
Neal Bhatia, MD: Topical Therapies Pipeline
Julie Harper, MD: What's New in Rosacea
Clive Maopang Liu, MD: Update on Topical Therapy for Psoriasis
Andrea Tesvich Murina, MD: Advancements in Oral Therapies for Psoriasis
Mark Lebwohl, MD: Special Factors to Consider in Elderly Patients with Psoriasis
Steven Daniel Daveluy, MD, FAAD: AI Phenotyping of Hidradenitis Suppurativa
Nada Elbuluk, MD: Skin of Color Primer—Inflammatory Diseases
1 2 3 206

Tags: